IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Valeant Pharmaceuticals

CUSIP: 91831AAC5 | 1 institutional holders

Quarters

Q3 2016Q2 2016Q1 2016Q4 2015Q3 2015
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2016

Advent Capital Management14,380,000
0.1% of portfolio›$12.4K
StyleTurnoverLocationFiled
Advent Capital Management
14,380,000$12.4K0.1%Deep ValueMediumNew York, NY2016-11-22